Scientists from Johns Hopkins and the University of Milan have proven that they can inhibit lethal human brain cancers in mice using a protein that selectively induces positive changes in the activity of cells that behave like cancer stem cells.

The bone morphogenic proteins cause neural stem-cell-like clusters to lose their stem-cell properties, which in turn stops their ability to divide.